1. Home
  2. BAFN vs RFL Comparison

BAFN vs RFL Comparison

Compare BAFN & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

HOLD

Current Price

$6.59

Market Cap

30.9M

Sector

Finance

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.49

Market Cap

61.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
RFL
Founded
1999
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Real Estate
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
61.1M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
BAFN
RFL
Price
$6.59
$1.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.3K
58.8K
Earning Date
04-30-2026
03-30-2026
Dividend Yield
1.22%
N/A
EPS Growth
133.93
28.28
EPS
N/A
N/A
Revenue
N/A
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$5.72
$1.12
52 Week High
$19.15
$3.19

Technical Indicators

Market Signals
Indicator
BAFN
RFL
Relative Strength Index (RSI) 44.36 76.62
Support Level $6.31 $1.41
Resistance Level $8.26 $1.60
Average True Range (ATR) 0.35 0.07
MACD -0.03 0.02
Stochastic Oscillator 6.34 75.61

Price Performance

Historical Comparison
BAFN
RFL

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: